腺氨酸激酶:一种新的药理目标,用于败血症引起的心脏功能障碍和多器官衰竭

Chiara Verra1, Maria Kerstin Paulmann2,3, Jamila Wegener2,3

  • 1Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.

Frontiers in immunology
|November 19, 2024
PubMed
概括

用腺氨酸激酶 (SYK) 抑制剂治疗败血症可以减少心脏功能障碍和多器官衰竭. 这表明SYK抑制是治疗败血症和炎症疾病的有希望的治疗策略.

相关概念视频